These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23535352)

  • 21. Serotonin and Antidepressant SSRIs Inhibit Rat Neuroendocrine Dopamine Neurons: Parallel Actions in the Lactotrophic Axis.
    Lyons DJ; Ammari R; Hellysaz A; Broberger C
    J Neurosci; 2016 Jul; 36(28):7392-406. PubMed ID: 27413150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the 5-HT system: Potential side effects.
    Hoyer D
    Neuropharmacology; 2020 Nov; 179():108233. PubMed ID: 32805212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-HT and depression: is the glass half-full?
    Sharp T; Cowen PJ
    Curr Opin Pharmacol; 2011 Feb; 11(1):45-51. PubMed ID: 21377932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of 5-HT receptors in depression.
    Yohn CN; Gergues MM; Samuels BA
    Mol Brain; 2017 Jun; 10(1):28. PubMed ID: 28646910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of 5-HT(2C) receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice.
    Clenet F; De Vos A; Bourin M
    Eur Neuropsychopharmacol; 2001 Apr; 11(2):145-52. PubMed ID: 11313160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
    Tordera RM; Monge A; Del Río J; Lasheras B
    Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from clinical studies.
    Haney EM; Warden SJ
    J Musculoskelet Neuronal Interact; 2008; 8(2):133-45. PubMed ID: 18622082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implication of 5-HT(2B) receptors in the serotonin syndrome.
    Diaz SL; Maroteaux L
    Neuropharmacology; 2011 Sep; 61(3):495-502. PubMed ID: 21277875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving the treatment of schizophrenia: role of 5-HT receptors in modulating cognitive and extrapyramidal motor functions.
    Shimizu S; Mizuguchi Y; Ohno Y
    CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):861-9. PubMed ID: 23844689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects.
    Turcotte JE; Debonnel G; de Montigny C; Hébert C; Blier P
    Neuropsychopharmacology; 2001 May; 24(5):511-21. PubMed ID: 11282251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies.
    Gardier AM; Malagié I; Trillat AC; Jacquot C; Artigas F
    Fundam Clin Pharmacol; 1996; 10(1):16-27. PubMed ID: 8900496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined In Silico, Ex Vivo, and In Vivo Assessment of L-17, a Thiadiazine Derivative with Putative Neuro- and Cardioprotective and Antidepressant Effects.
    Sarapultsev A; Vassiliev P; Grinchii D; Kiss A; Mach M; Osacka J; Balloova A; Paliokha R; Kochetkov A; Sidorova L; Sarapultsev P; Chupakhin O; Rantsev M; Spasov A; Dremencov E
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managing epilepsy-associated depression: Serotonin enhancers or serotonin producers?
    Singh T; Goel RK
    Epilepsy Behav; 2017 Jan; 66():93-99. PubMed ID: 28038393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [5-HT1B serotonin receptors and antidepressant effects of selective serotonin reuptake inhibitors ].
    Gardier AM; Trillat AC; Malagié I; David D; Hascoët M; Colombel MC; Jolliet P; Jacquot C; Hen R; Bourin M
    C R Acad Sci III; 2001 May; 324(5):433-41. PubMed ID: 11417564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional distribution of serotonergic receptors: a systems neuroscience perspective on the downstream effects of the multimodal-acting antidepressant vortioxetine on excitatory and inhibitory neurotransmission.
    Pehrson AL; Jeyarajah T; Sanchez C
    CNS Spectr; 2016 Apr; 21(2):162-83. PubMed ID: 26250622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-HT(1A)-receptor over-expressing mice: genotype and sex dependent responses to antidepressants in the forced swim-test.
    Günther L; Rothe J; Rex A; Voigt JP; Millan MJ; Fink H; Bert B
    Neuropharmacology; 2011 Sep; 61(3):433-41. PubMed ID: 21419787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-HT Receptors and the Development of New Antidepressants.
    Ślifirski G; Król M; Turło J
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The neurobiology and pharmacology of depression. A comparative overview of serotonin selective antidepressants.
    Harvey BH
    S Afr Med J; 1997 Apr; 87(4 Suppl):540-50, 552. PubMed ID: 9180828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Selective serotonin reuptake inhibitor(SSRI)].
    Motohashi N
    Nihon Rinsho; 2001 Aug; 59(8):1519-22. PubMed ID: 11519151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.